Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.
about
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNACytopathic Mechanisms of HIV-1Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcriptionChemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptaseNovel inhibitory effects of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1 production and propagation.Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.HIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus.HIV-1 pre-integration complexes selectively target decondensed chromatin in the nuclear periphery.APOBEC3G inhibits elongation of HIV-1 reverse transcripts.Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1RNA-protein interactions govern antiviral specificity and encapsidation of broad spectrum anti-HIV reverse transcriptase aptamersCovert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytesATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.Genomic flexibility of human endogenous retrovirus type KSubtype-associated differences in HIV-1 reverse transcription affect the viral replication.R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitorsPotent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 monthsStructural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes.Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders.Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantificationPrimer tRNA3Lys on the viral genome exists in unextended and two-base extended forms within mature human immunodeficiency virus type 1.CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A.Visualization of the intracellular behavior of HIV in living cells.Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitroA protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.Unclosed HIV-1 capsids suggest a curled sheet model of assemblyIn vitro synthesis of long DNA products in reactions with HIV-RT and nucleocapsid protein.Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcriptionTissue-specific HIV-1 infection: why it matters.When is it time for reverse transcription to start and go?Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection.New insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3.Cellular minichromosome maintenance complex component 5 (MCM5) is incorporated into HIV-1 virions and modulates viral replication in the newly infected cells.
P2860
Q24305266-C0D68570-1D37-427A-A6E2-5E0C080176A4Q27485043-DF6671DC-B5E4-420B-B81B-5E5DDAF0E2B0Q28359887-8FA8B2BE-D94C-402F-922C-8F35D88B829DQ28379510-134E0C38-FE08-44D2-8DD9-6D85A2845A2BQ28379516-D02AC279-B7A4-4D01-AB5B-AEA297E6825DQ30350882-997331AD-F5F8-489C-84E4-6C2231C70AD7Q30369511-F5AC7E15-ED0F-44CF-9A14-7FA3513255ACQ33342802-13D51388-46C4-4A82-9947-1180C03E76EEQ33389841-6D66DA27-1379-4C19-A77F-E8F5749544CBQ33700962-86814D9A-BFAF-4C4E-A462-FE753D02194AQ33741016-01F21B18-CB91-4CAC-B60A-1850D0BD5FB8Q33755099-7A470C93-1D10-40AB-8EB1-A60515BED136Q33755116-7A6EF5C4-931E-4B9D-8868-D823ECCBFD4BQ33782781-30B25C9C-D443-43C1-822A-CB57ACA2E8F7Q33844166-795FD42F-07ED-4EB0-A61F-165FCC370C0AQ33869997-5244FD7F-EC28-4D19-BF67-3C30D2678015Q34059466-D327FCE1-2FF4-40C3-9E5F-9D8FCFC0E3A7Q34243467-C844D1DE-433B-4518-BF7A-483009E3A827Q34301688-299382E6-8A65-4897-B118-FC37229A3811Q34312616-A8380A4C-63BD-485A-A107-4392E750834BQ34465982-184C9FF2-677B-4A82-9355-A471E3313F99Q35155063-14B4D5E3-6C61-4C98-B910-B555FD71E825Q35424138-6D3ADAC1-5189-4F51-A2B2-2C47963C20B8Q35636068-B1EEBE18-2B16-426E-B9EE-2B99E5FF667CQ35875824-2B86CDD2-A908-4222-BE0E-63195AEE8DDAQ35943551-FD01CDA8-AE7A-48FF-A53B-07556C5C0F29Q36323740-5532BFA9-71A9-4217-B52D-F6D9ACCD7FCAQ36424184-F1496B24-E842-46B3-B080-5E9424EC4228Q36553297-ED200D3F-5A45-4BB6-B3AD-B9D9B6371AB1Q36683302-370C44D0-DBF3-43A8-BE6A-C32FB2457E1BQ36804480-AA84E816-90F5-43CA-8C60-CAC627CF2A28Q36898781-48FE9675-EBE5-4617-AFA2-6DE75120BD4EQ37089202-8E7703C5-9E49-444A-B2E4-F18F3D890F8DQ37130269-DC632470-76E0-42AE-BF91-00A788EFBD1CQ37233039-D2AE68A4-A2C4-460E-87BE-7707F5BD5D1EQ37242308-C45FFF81-F63A-44EA-ADF9-6D6E5B14C769Q37251114-98126596-C8CA-44B3-8E37-E3159C6A3116Q37256671-254CF2D0-B9F7-43B1-8CC9-273BC4F03615Q37320502-42111016-EC4F-43E3-827F-3C009FCB1862Q37365605-7FA1FE91-574C-4D3E-9187-E9A3F7CB1158
P2860
Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Endogenous reverse transcripti ...... nfection of nondividing cells.
@ast
Endogenous reverse transcripti ...... nfection of nondividing cells.
@en
type
label
Endogenous reverse transcripti ...... nfection of nondividing cells.
@ast
Endogenous reverse transcripti ...... nfection of nondividing cells.
@en
prefLabel
Endogenous reverse transcripti ...... nfection of nondividing cells.
@ast
Endogenous reverse transcripti ...... nfection of nondividing cells.
@en
P2093
P2860
P1433
P1476
Endogenous reverse transcripti ...... nfection of nondividing cells.
@en
P2093
G Dornadula
R J Pomerantz
P2860
P304
P407
P577
1996-05-01T00:00:00Z